BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10852052)

  • 1. [The effect of platelet-activating factor and its antagonist--BN 52021--on immune reactions in vivo in mice and in vitro].
    Poveshchenko AF; Kozlov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):53-6. PubMed ID: 10852052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
    J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
    Jancar S; Braquet P; Sirois P
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
    Földes-Filep E; Braquet P; Filep J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of eicosanoids in platelet-activating factor-induced modulation of adenylyl cyclase activity in alveolar macrophages.
    Beusenberg FD; van Schaik A; van Amsterdam JG; Bonta IL
    J Lipid Mediat; 1991; 3(3):301-9. PubMed ID: 1663403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei.
    Grassi S; Francescangeli E; Goracci G; Pettorossi VE
    J Neurophysiol; 1998 Jun; 79(6):3266-71. PubMed ID: 9636125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
    Stewart AG; Dusting GJ
    Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances.
    Becker K; Lueddeckens G; Grupe R; Förster W
    Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):265-71. PubMed ID: 8385779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products.
    Bazan HE; Reddy ST; Woodland JM; Bazan NG
    Biochem Biophys Res Commun; 1987 Dec; 149(3):915-20. PubMed ID: 2827658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three paf-acether receptor antagonist ginkgolides.
    Korth R; Nunez D; Bidault J; Benveniste J
    Eur J Pharmacol; 1988 Jul; 152(1-2):101-10. PubMed ID: 2850196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.
    Cruzado JM; Torras J; Riera M; Lloberas N; Herrero I; Condom E; Martorell J; Alsina J; Grinyó JM
    Clin Exp Immunol; 1998 Jul; 113(1):136-44. PubMed ID: 9697996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
    Hostettler ME; Knapp PE; Carlson SL
    Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelet-activating factor (PAF) in the initiation of the decidual reaction in the rat.
    Acker G; Braquet P; Mencia-Huerta JM
    J Reprod Fertil; 1989 Mar; 85(2):623-9. PubMed ID: 2703999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elvax as a slow-release delivery agent for a platelet-activating factor receptor agonist and antagonist.
    Bix GJ; Clark GD
    J Neurosci Methods; 1997 Nov; 77(1):67-74. PubMed ID: 9402559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of platelet-activating factor receptors, induced by inflammation in guinea pig ileal smooth muscle cells.
    Jeanneton O; Delvaux M; Frexinos J; Bueno L
    Gastroenterology; 1995 Jun; 108(6):1666-75. PubMed ID: 7768370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of PAF-acether on the dog kidney.
    Hébert RL; Sirois P; Braquet P; Plante GE
    Prostaglandins Leukot Med; 1987 Mar; 26(3):189-202. PubMed ID: 3033688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin.
    Thielman NM; Marcinkiewicz M; Sarosiek J; Fang GD; Guerrant RL
    J Clin Invest; 1997 Apr; 99(8):1999-2004. PubMed ID: 9109445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.